Answers are grounded in this paper and cite their sources.
Respiratory viruses, including influenza, RSV, and SARS-CoV-2, hijack host metabolic machinery to facilitate their replication and evade immune surveillance. This review synthesizes current evidence on the bidirectional interplay between viral-induced metabolic reprogramming – specifically the upregulation of glycolysis, lipogenesis, and glutaminolysis, and the disruption of mitochondrial homeostasis – and the host immune response. We highlight how this metabolic rewiring not only provides biosynthetic precursors for viral proliferation but also modulates immune cell differentiation and inflammatory outcomes. Furthermore, we discuss how preexisting host metabolic conditions (e.g. obesity, diabetes, aging) exacerbate disease severity through this metabolic-immune axis, and how persistent metabolic alterations may underlie post-acute sequelae such as Long COVID. Finally, we evaluate the therapeutic potential and challenges of targeting metabolic checkpoints, such as mTOR and SREBP, to balance antiviral efficacy with immune homeostasis. PubMed was searched for articles from database inception to July 2026.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: